EVALUATION OF 5-YEAR SURVIVAL OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ. 2026;67(Số CĐ12- Bệnh viện Ung bướu Nghệ An). doi:10.52163/yhc.v67iCD12.6134